1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Sinew Pharma Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLD SNP-612 dose1, SNP-612 dose2 - NASH - Nonalcoholic Steatohepatitis | Phase 2 | Terminated | Sinew Pharma Inc. | 90 | 2017-08-04 | 2023-01-06 |
Non-alcoholic Fatty Liver Disease (1)
Taiwan (1)